| 13.795 1.075 (8.45%) | 05-07 14:29 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 17.9 | 1-year : | 19.97 |
| Resists | First : | 15.32 | Second : | 17.1 |
| Pivot price | 13.93 |
|||
| Supports | First : | 12.46 | Second : | 10.37 |
| MAs | MA(5) : | 13.94  |
MA(20) : | 13.98 |
| MA(100) : | 17.9 |
MA(250) : | 38.37 |
|
| MACD | MACD : | -0.7 |
Signal : | -0.9 |
| %K %D | K(14,3) : | 29.6 |
D(3) : | 37.8 |
| RSI | RSI(14): 44.6 |
|||
| 52-week | High : | 96.86 | Low : | 12.46 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ LABD ] has closed above bottom band by 49.3%. Bollinger Bands are 18.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.75 - 13.86 | 13.86 - 13.94 |
| Low: | 12.45 - 12.56 | 12.56 - 12.64 |
| Close: | 12.57 - 12.75 | 12.75 - 12.87 |
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.
Wed, 06 May 2026
Direxion Daily AVGO Bull 2X Shares (NASDAQ:AVL) Shares Up 5.3% - Time to Buy? - MarketBeat
Mon, 04 May 2026
Direxion Daily S&P 500 High Beta Bear 3X Shares ETF declares quarterly distribution of $0.0677 - MSN
Tue, 21 Apr 2026
Direxion Daily S&P 500 Bull 2X Shares declares quarterly distribution of $0.3216 - MSN
Tue, 21 Apr 2026
Direxion Daily S&P 500 Bear 1X Shares declares quarterly distribution of $0.0516 - MSN
Mon, 20 Apr 2026
Direxion Daily MU Bull 2X Shares (NASDAQ:MUU) Stock Price Down 5.5% - Time to Sell? - MarketBeat
Sun, 15 Mar 2026
SPXL vs. TQQQ: Is S&P 500 Stability or Tech-Focused Growth the Better Buy for Leveraged ETF Investors? - The Motley Fool
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management - Leveraged
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|